BPC 157 therapys effects are safe concerning the cure of each organ involved, including the brain, heart, lung, liver, kidney, and gastrointestinal tract, and it does not produce any adverse effect on account of its beneficial effects [129,130,131,132,133,134,135,136,137,138,139,140,141,142,168], along with other findings, i.e., so far no reported adverse effects in basic research, LD1 not achieved, no adverse effects in clinical trials [3,4,5,6,7,8,9,10,11,12,13,14,16,17,18,19,20,21,22,23,24,27,28,29,30,31,32,34,37,39,40]
How GLP-1 and Dual GIP/GLP-1 Agonists Work to Treat Obesity GLP-1 agonists and dual GIP/GLP-1 agonists are medications that increase satiety (the feeling of fullness), slow digestion, and quiet constant thoughts about food (known as food noise), making it easier to lose weight and keep it off
Saxenda (Liraglutide)
Given its neurotrophic properties, mature BDNF is essential for neuronal plasticity and learning 1,4,7,10